ProCE Banner Activity

Perspectives From Australia: Key Studies From IDWeek and HIV Glasgow 2024

Conference Coverage
Clinical Thought

At IDWeek and HIV Glasgow 2024, studies on cancer treatment in people living with HIV, antiretroviral therapy adverse events, and mpox coinfection had relevance to Australia. Here is my summary.

Released: December 16, 2024

Expiration: December 15, 2025

Share

Faculty

Sharon R. Lewin

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor and Head, Department of Infectious Disease
The University of Melbourne
Consultant Physician
Royal Melbourne and Alfred Hospitals
Melbourne, Australia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare